Market Research Logo

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

GlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufactures and markets prescription medicines and vaccines. The prescription medicines range across therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, central nervous system (CNS) and oncology. The company offers a range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus, tetanus toxoid, reduced diphtheria toxoid, human papillomavirus vaccine and others. The company is a subsidiary of GlaxoSmithKline Plc, which has operations across pharmaceuticals, vaccines and consumer health domains. GSK India is headquartered in Mumbai, Maharashtra, India.

GlaxoSmithKline Pharmaceuticals Limited Key Recent Developments

Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth
Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services
Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration
Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract
Sep 08, 2015: GSK Initiates Work On Pharmaceutical Facility In Karnataka, India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
GlaxoSmithKline Pharmaceuticals Limited - Key Facts
GlaxoSmithKline Pharmaceuticals Limited - Key Employees
GlaxoSmithKline Pharmaceuticals Limited - Key Employee Biographies
GlaxoSmithKline Pharmaceuticals Limited - Major Products and Services
GlaxoSmithKline Pharmaceuticals Limited - History
GlaxoSmithKline Pharmaceuticals Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
GlaxoSmithKline Pharmaceuticals Limited - Business Description
GlaxoSmithKline Pharmaceuticals Limited - Corporate Strategy
GlaxoSmithKline Pharmaceuticals Limited - SWOT Analysis
SWOT Analysis - Overview
GlaxoSmithKline Pharmaceuticals Limited - Strengths
Strength - Parent Synergy
Strength - Focused Research Activities
Strength - Strong Market Position
GlaxoSmithKline Pharmaceuticals Limited - Weaknesses
Weakness - Anti-Competitive Practices
Weakness - Declined Sales
GlaxoSmithKline Pharmaceuticals Limited - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Changing Demographics
Opportunity - Facility Expansions
GlaxoSmithKline Pharmaceuticals Limited - Threats
Threat - Government Regulations
Threat - Uncertain R&D Outcomes
Threat - Competitive Landscape
GlaxoSmithKline Pharmaceuticals Limited - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
GlaxoSmithKline Pharmaceuticals Limited, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth
Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services
Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration
Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration
Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract
Sep 08, 2015: GSK Initiates Work On Pharmaceutical Facility In Karnataka, India
Aug 02, 2015: GSK India’s Greenfield Manufacturing Facility At Bengaluru To Begin Operations In 2017
Jun 22, 2015: GlaxoSmithKline Pharmaceuticals appoints Annaswamy Vaidheesh as MD
Jun 08, 2015: GSK Considering All Options Against CCI Order
Feb 12, 2015: GlaxoSmithKline Pharmaceuticals announces Q4 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
GlaxoSmithKline Pharmaceuticals Limited, Key Facts
GlaxoSmithKline Pharmaceuticals Limited, Key Employees
GlaxoSmithKline Pharmaceuticals Limited, Key Employee Biographies
GlaxoSmithKline Pharmaceuticals Limited, Major Products and Services
GlaxoSmithKline Pharmaceuticals Limited, History
GlaxoSmithKline Pharmaceuticals Limited, Joint Venture
GlaxoSmithKline Pharmaceuticals Limited, Key Competitors
GlaxoSmithKline Pharmaceuticals Limited, Ratios based on current share price
GlaxoSmithKline Pharmaceuticals Limited, Annual Ratios
GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
GlaxoSmithKline Pharmaceuticals Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
GlaxoSmithKline Pharmaceuticals Limited, Performance Chart (2012 - 2016)
GlaxoSmithKline Pharmaceuticals Limited, Ratio Charts
GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report